Imagion Biosystems has released its Quarterly Cashflow Report for the period ending 30 September 2019.
Read Appendix 4C.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell